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Abstract 
Background: A detailed neuropsychological assessment plays an important role in the 
diagnostic process of Mild Cognitive Impairment (MCI). However, available brief cognitive 
screening tests for this clinical population are administered and interpreted based mainly, or 
exclusively, on total achievement scores. This score-based approach can lead to erroneous 
clinical interpretations unless we also pay attention to the test taking behaviour or to the type 
of errors committed during test performance.  
Methods: The goal of the current study is to perform a rapid review of the literature 
regarding cognitive screening tools for dementia in primary and secondary care; this will 
include revisiting previously published systematic reviews on screening tools for dementia, 
extensive database search, and analysis of individual references cited in selected studies. 
Results: A subset of representative screening tools for dementia was identified that 
covers as many cognitive functions as possible. How these screening tools overlap with each 
other (in terms of the cognitive domains being measured and the method used to assess them) 
was examined and a series of process-based approach modifications for these overlapping 
features were proposed, so that the changes recommended in relation to one particular 
cognitive task could be extrapolated to other screening tools.  
Conclusion: It is expected that future versions of cognitive screening tests, modified 
using a process-based approach, will highlight the benefits of attending to qualitative features 
of test performance when trying to identify subtle features suggestive of MCI and/or 
dementia. 
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Multiple concepts have been proposed to capture the connection between the 
subclinical cognitive changes associated with age and pathological alterations in cognition 
(e.g. Mild Cognitive Decline, Mild Neurocognitive Decline, Cognitive Impairment-No 
Dementia, Mild Cognitive Impairment) (Ritchie & Touchon, 2000). Of these, by far the most 
widely adopted in both research and clinical practice is that of Mild Cognitive Impairment 
(MCI), referring to a clinical syndrome that represents an intermediate but abnormal state of 
cognitive impairment between normal ageing and dementia (Petersen, Smith, Waring, Ivnik, 
Tangalos, & Kokmen 1999). Initially focusing exclusively on memory impairment, 
considered prodromal to Alzheimer’s disease, MCI is now considered a broad construct, 
heterogeneous in its clinical presentations, with several neuropsychological syndromes or 
clinical subtypes having been identified (i.e. MCI amnestic single or multiple domains and 
non-amnestic single and multiple domain) which are potentially due to multiple aetiologies 
(e.g. Alzheimer’s disease, vascular disease, etc.) (Petersen et al., 2014; Winblad et al., 2004). 
The heterogeneous aetiology of MCI is reflected in the findings from cumulative conversion 
rates, which show a 30% conversion to any type of dementia, coupled with high rates of 
reversion to a non-clinical status (Ritchie & Ritchie, 2012). 
More recently, the Diagnostic and Statistical Manual of Mental Disorders, Fifth 
Edition (DSM-5), in an effort to capture the pre-dementia stage of cognitive impairments 
includes the term ‘mild neurocognitive disorder’ (mNCD). This concept is derived almost 
exclusively from previous research in MCI (Sachs-Ericsson & Blazer, 2015) and its 
operational criteria resemble the revised Mayo Clinic criteria for MCI (Winblad et al., 2004) 
in that there has to be (i) concern expressed by the individual or an informant or observations 
made by the clinician; (ii) objective impairment in one or more cognitive domains, preferably 
documented by standardised neuropsychological testing; and (iii) preserved independence in 
functional abilities. Although the construct of mNCD also represents a heterogeneous 
category, compared to the concept of MCI it encompasses a more diverse group of entities, 
including mild acquired impairments in younger individuals and impairments that may be 
transient, static, or even reversible. The terms mNCD and MCI are not, therefore, 
interchangable. That being said, as we intend to focus on early detection of dementia, we will 
stick to the widely used term of MCI as a non-reversible condition that precedes dementia 
and will focus on how that detection can be improved with the resources available in a 
common primary care setting.  
In Ireland, 4,000 new cases of dementia are detected ever year and there are currently 
approximately 41,470 people living with dementia, which is expected to triple by 2050, 
constituting a challenge for patients and their families, professionals and society at large 
(Cahill, O’Shea & Pierce, 2012). Not surprisingly, early detection of MCI and dementia and 
the identification of the specific underlying disease causing these syndromes in order to treat 
them is a public health priority. Among other medical investigations, including functional 
assessment, biological markers and neuroimaging techniques, a detailed objective cognitive 
evaluation is considered to play an important role in the diagnostic process (Albert et al., 
2011).  
Although objective evidence of cognitive decline is a core feature of MCI, 
establishing the demarcation between normal cognition and MCI and indeed between MCI 
and dementia is not straightforward for a number of reasons.  
First, there are, as yet, no universally accepted, or indeed recommended, guidelines as 
to what set of cognitive tests should be used to detect MCI, although most criteria allude to 
the importance of examining all the main cognitive areas (Petersen et al., 2014). In this vein, 
with reference to the identification and clinical characterisation of MCI cases of the amnestic 
subtype (aMCI) participating in clinical trials, Stephan et al. (2013) detected a large 
heterogeneity in the neuropsychological methods used to determine memory impairment in 
different trials, together with a lack of uniformity in the clinical diagnosis of this syndrome, a 
problem that the authors felt extends to other clinical states such as dementia including 
Alzheimer’s disease, Lewy Body, or frontotemporal or vascular dementia. 
Second, although cognitive decline or impairment that “falls below the expected 
level” (DSM-5) or is “beyond that expected for both age and education level” (Petersen et al., 
1999) is an essential part of the operation criteria for MCI, there is no gold standard or even 
widely accepted cut-off scores to operationalize this concept which is complicated by the fact 
that few cognitive tests have adequate norms for the oldest old (i.e. ≥90 years). With 
relatively little empirical justification, the Mayo Clinic Criteria for MCI uses a cut off score 
of 1 – 1.5 standard deviations below normative values although fulfilment of this criteria is 
ultimately determined through clinical judgement (Winblad et al., 2004), whereas the new 
DSM-5 criteria for mNCD suggest using a wider spectrum with performance typically lying 
in the 1-2 standard deviation range (between the 3rd percentile and 16th percentile). These 
discrepancies inevitably lead to considerable variation in prevalence and conversion rates 
(Marcos et al., 2016; Ritchie & Ritchie, 2012; Ritchie & Touchon, 2000). 
Third, current MCI criteria establish the requirement of objective cognitive 
impairment in one or more cognitive domains but there is ambiguity regarding the number of 
impaired indices or cognitive measures needed to fulfil cognitive syndrome criteria (Petersen 
et al., 2014). Furthermore, establishing that a particular defective score on a given cognitive 
measure is the result of cognitive impairment in the cognitive domain that the test portrays to 
measure, may lead to spurious clinical conclusions as any cognitive test, by its very nature, is 
multifactorial and places demands on more than just one cognitive process. For example, so 
called visuoconstruction tasks, such as the clock drawing, rely not only on visuospatial 
processes but also on semantic memory and executive control (Rouleau, Salmon & Butters, 
1996). 
 Fourth, while an in-depth neuropsychological evaluation of a wide range of cognitive 
domains is considered to be optimal for the detection and clinical differentiation of MCI 
subtypes, access to tertiary services such as memory clinics with the full complement of 
neuropsychological evaluation is relatively rare and most clinical cognitive examinations are 
conducted using brief cognitive screening measures for different purposes in a variety of 
clinical settings with different levels of specialist training in administration and interpretation 
of cognitive test performance (Lonie et al., 2010). In a previous systematic review of 15 
different cognitive screening instruments –most of which were designed to detect early and 
moderate stage dementia – Lonie, Tierney and Ebmeier (2009) concluded that while several 
of these measures afforded the clinician the ability to detect MCI, none of them wholly 
fulfilled all the criteria considered to be important in MCI screening. More specifically, these 
authors could not find data about (1) sensitivity for early atypical dementia presentations, (2) 
test specificity when compared with psychiatric and non-progressive neurological conditions, 
(3) cross-cultural usage and (4) reliability and predictive validity.  
The cognitive screening tools typically used to detect MCI in clinical practice differ in 
terms of the number of cognitive domains they cover, some covering each of the primary 
cognitive domains of cognitive function, typically referred to as “comprehensive” and others 
providing only partial cover “non-comprehensive” (Lonie et al 2009; 2010). However, and in 
relation to the core of the present review, what they do have in common is that their 
administration and method of interpretation rely almost exclusively on a total achievement 
score. In fact, all of them provide a cut-off score for ease of interpretation and an impaired 
overall score is typically used to detect MCI in research studies and clinical practice. There 
are, however, many limitations with this standard restrictive ‘quantitative method’ of 
interpretation of cognitive test performance that, in many cases, can lead to erroneous clinical 
interpretations. As previously noted, an impaired score on a given test can be attributable to a 
range of underlying cognitive deficits, the nature of which would be hidden under a single 
index score.  
In order to circumvent this shortcoming, in this review we propose to complement the 
traditional quantitative analysis of test performance in cognitive screening measures with the 
qualitative methodology developed by Kaplan (1988) which emphasizes the importance of 
the analysis of processes and errors in understanding brain-behaviour relationships. To 
elaborate, beyond a ‘traditional’ cognitive evaluation that pays attention almost exclusively to 
‘how much’ a person achieves on a cognitive task (total test score), a more qualitative, 
process-based, approach that observes ‘how’ a task is completed (i.e. what kind of cognitive 
strategies are adopted) and ‘why’ the person fails on the task, can aid in the process of early 
and differential diagnosis of MCI. To illustrate, two patients, with different underlying 
neuropathology, may obtain exactly the same score in a cognitive test but the way in which 
they approach the task, as well as the specific underlying cognitive strategies that they recruit 
to attain the score, may be very different. Moreover, the reason for their failure in completing 
the task may also differ. This rich qualitative information can be invaluable for clinicians in 
their quest to determine the most likely underlying pathology responsible for cognitive 
failure. 
This approach to understanding the underlying cognitive processes by means of 
paying attention to test taking behaviour and types of errors committed is widely known as 
the process-based approach (PBA), or Boston Process-Approach (BPA), to 
neuropsychological evaluation. According to Milberg, Hebben and Kaplan (1986), the BPA 
is a result of the work started by Edith Kaplan in the late ‘60s at the Clinical 
Neuropsychological Services at the Boston Veterans Administration Medical Center (USA), 
and derives from the gradual combination of tests that had been proven valid in the clinical 
discrimination of patients with and without brain damage with tests that purported to measure 
narrow specifiable cognitive functions. Kaplan and her team performed careful systematic 
observations of the problem-solving strategies used by patients (i.e. the way they successfully 
solved or failed to solve each problem presented to them). The resulting method allowed both 
a quantitative assessment of a patient’s performance and a dynamic serial “picture” of the 
information-processing style that each patient used.  
 With the advantages of such an approach in mind, the goals of the current study are to 
(1) perform a rapid review of the literature regarding cognitive screening tools for MCI and 
dementia in primary and secondary care; this will include revisiting previously published 
systematic reviews on screening tools for dementia, extensive database search, and analysis 
of individual references cited in selected studies, (2) identify a subset of representative 
screening tools for dementia that cover as many cognitive functions as possible, (3) identify 
how these cognitive screening tools overlap with each other (in terms of the cognitive 
domains being measured and the method used to assess them), and (4) propose a series of 
process-based approach modifications for these overlapping features, so that the changes 
recommended in one particular cognitive task can be extrapolated to the same task as it 
appears in the other screening tools. 
Methodology 
Searching strategy 
Screening tests were identified by searching electronic databases (PubMed, PsycINFO 
and Ingenta Connect), using combinations of the terms already used by Cullen et al. (2007) in 
their systematic review (“dementia”, “Alzheimer”, “cognitive impairment”, “post stroke”, 
“screen”, “primary care” and “community”) in order to replicate the findings and to update 
the existing tools for the last 10 year period. The search was complemented with the 
combination of words “cognitive screening”, “screen”, “systematic review”, “MCI”, 
“Alzheimer”, “dementia”, and excluding words “children” and “schizophrenia”, in order to 
address those existing systematic reviews that have been performed for the last 10 years since 
the work by Cullen et al. (2007). Additionally, databases were searched for the terms “Boston 
process approach”, “qualitative error analysis” and “quantified process approach” (to ensure 
inclusion of the work performed by Poreh (2000) to systematise the previous work done by 
Kaplan and colleagues on the BPA), in order to find out not only additional tests but also 
procedures and variables that could have already been used in the adaptation of existing tests 
to a process-based approach. Individual test names were also used as search terms and the 
reference lists of papers yielded were manually searched for those studies identified as 
relevant when reviewing citations.  
 
Selection strategy 
 The total number of tests identified as used in the evaluation of MCI and dementia by 
means of different sources was 160, a number that was reduced to 153 after duplicated were 
removed. Those tests already conceived or modified using a process-based approach to 
cognitive evaluation (n = 48) were excluded from the eligibility study, as the goal was to 
identify tests that were not yet modified but could potentially benefit from modifications 
using this approach.  
Results 
Figure 1 shows the PRISMA Diagram about the process followed from the initial 
identification of potential tests modifiable using a PBA. 
(INSERT FIGURE 1 HERE) 
A total list of 105 potential tests was identified. At this point, the following inclusion 
criteria were followed to determine a potential group of screening tools that could be taken 
into further consideration for MCI screening: 
- Tests that measure a minimum of 3 of the 6 cognitive domains mentioned in the 
diagnosis of dementia according to the Diagnostic and Statistical Manual of mental 
Disorders, Fifth Edition (DSM-5), namely, complex attention, executive function, 
learning and memory, language, perceptual-motor function, and social cognition.  
- Tests that were designed for dementia or that are widely used in dementia assessment 
once there is a well-established diagnosis. 
- Tests fulfilling the Quality Assessment tool for Diagnostic Accuracy Studies 
(QUADAS) (Whiting et al., 2003) (see Table 1). 
(INSERT TABLE 1 AROUND HERE) 
- Interviews, observation scales or informant ratings, computer tasks and remote-
screening instruments (for example, telephone administered tests) were excluded, as 
well as tests being in languages other than English.  
- An additional number of tests that were unavailable, out of print, or restricted to a 
specific geographic area in the world, were also excluded. 
The application of this selection strategy led to the exclusion of another 84 tests, thus 
leading to a list of potential 21 screening tests for further quality review. None of these tests 
had previously undergone significant changes using a process-based approach.  
Quality review strategy 
The quality review of these 21 tests showed that some had copyright conflicts for 
research use (e.g. MMSE), some were specifically designed for a particular type of dementia 
once the diagnosis was established (e.g. ADAS-Cog), were also excluded. One test (i.e. 
Cognitive Abilities Screening Instrument -CASI) was excluded based on the recommendation 
done by the main author of the test herself. Finally, tests that require high qualification levels 
to administer, that is, they cannot be administered by a wide range of professionals were 
excluded (unless they met the QUADAS criteria, as maybe with a process-based approach 
administration and scoring, the level of widespread use among different professionals can be 
extended). This criteria of potential benefits derived from a BPA were only applied to the 
Repeatable Battery for Neuropsychological Status (RBANS), which was included due to its 
widespread use and popularity among a wide range of clinicians. 
The outcome of the quality review is a list of 7 screening tools in Table 2. None of 
these tests has previously undergone a process-based approach, or have, at most, undergone a 
qualitative error analysis approach.  
(INSERT TABLE 2 AROUND HERE) 
Data extraction: identification of cognitive tasks’ overlap 
We identified the cognitive tasks that were shared, albeit with subtle variations, 
between these cognitive screening tools. The following overlapping features were identified 
between different selected tests:  
1. MoCA, ACE-III, RUDAS, and STMS include the copy of a cube as a 
visuoconstructional task. 
2. MoCA, ACE-III, STMS, SLUMS, and Brief KSCA-R include some version of clock 
drawing. 
3. Verbal fluency is present in the MOCA (letter F), ACE-III (letter P and animals), 
RUDAS (animals), SLUMS (animals), and RBANS (fruits and vegetables) 
4. MoCA, STMS, and Brief KSCA-r comprise a similarities subtest for abstraction. 
5. MoCA, ACE-III, RUDAS, SLUMS and STMS include short-term recall of a series of 
3 to 5 words, while RBANS includes a 10-word list with 4 trials for immediate 
memory, one for delayed free recall and one for recognition. 
6. MoCA, SLUMS and STMS include digit span, but it is only digit forward for STMS 
and RBANS, and only backward for SLUMS, while MoCA includes both. 
Proposal for modifications using a process-based approach 
 In order to develop process-based approach versions of cognitive screening tasks, we 
drew from the work of different authors who have already shown how the analysis of errors 
conveys additional information regarding underlying brain/ behaviour relations (e.g., Trail 
Making Test or verbal fluency). We took inspiration from the previous work by Price et al. 
(2011), who had already indicated the benefits of the analysis of errors as produced on the 
Clock Drawing Test drawing in the MoCA subtest; and the benefits of adding a copy 
condition to help identify the primary underlying cognitive deficits responsible for errors in 
the command condition. We also drew from the work of Hodges, Salmon and Butters (1991) 
on the error analysis of the Boston Naming Test, proving to be very effective beyond the 
overall achievement score in distinguishing between Huntington’s disease and Alzheimer’s 
disease. Furthermore, the analysis of errors presented for the fluency task is inspired by the 
work of Troyer, Moscovitch and Winocur (1997). 
Informed by the methodological framework of the Process Based Approach, we 
employ two main methodologies (Poreh, 2000) in order to capture the underlying cognitive 
deficits responsible for test underperformance:  
- The “Satellite” Testing Paradigm: This approach consists of the inclusion of 
complimentary conditions to the existing cognitive task with the aim of isolating the 
individual cognitive processes necessary for its completion in order to assist in the 
identification of the precise nature of the cognitive deficit responsible for test 
performance on the original cognitive task. Using this paradigm, satellite conditions 
for the Clock Drawing Task (e.g. copy and tracing conditions) and the Naming Task 
(i.e. semantic and phonetic cue) were introduced.  
- Composition Paradigm: This approach consists of the generation of new indices in 
already existing cognitive task, using the data that has already been derived from the 
standardized administration of this task but not previously analysed. New indices are 
derived for Verbal Fluency tests (i.e. switching and clustering) and Memory tasks 
(e.g. gained and lost access). A series of qualitative classifications of errors are 
proposed for a series of tasks including Trail Making, Clock Drawing, Verbal 
Fluency, and Memory. 
Due to the described overlapping of some of the subtests or items included throughout 
different cognitive screening measures, it was possible to identify how to easily implement 
process-based approach modifications to particular cognitive screening tasks that may be 
extrapolated to all administration procedures among the different tests containing the same 
task, as shown below:  
1. Visuoconstructional tasks (copy cube): as we stated above, MoCA, ACE-III, RUDAS, 
and STMS include the copy of a cube as a visuoconstructional task, though the one in 
STMS is flipped 180 degrees horizontally. In this case, the following indices are 
proposed: (1) the test respondent represents a 2D shape instead of the 3D model 
(which may reflect a contrast sensitivity deficit) (Cronin-Golomb, 2011) (2) drawing 
overlaps model (pull to stimulus): the test taker draws partially over the given model; 
(3) lines missing: it may reflect visuoperceptive or attentional problems (spatial 
positioning error); (4) motor perseveration in line drawing; (5) tremor or 
segmentation, and (5) rotation. 
2. Clock drawing: Variations among different screening tests are very heterogeneous and 
obtained information depends on the type of conditions administered (command, 
copy, tracing). Interestingly, the BKSCA-R breaks down the tasks of writing the 
numbers (“I want you to write in the numbers, as on a clock face”) and writing the 
hands (“and on this circle draw in the hands to make it say 9 o’clock”), followed by a 
clock in which only hands must be drawn to set time, and a last clock on which time 
must be read. After the administration of all different tests that include one or other 
type of clock drawing condition, it is considered of great interest to take into 
consideration that modifications performed to the clock drawing just with the 
inclusion of a copy (Price et al., 2011) and a tracing condition (Evans, Coen, Burke & 
Lawlor, 2005) can be the most comprehensive approach for the evaluation of the 
following areas: graphomotor performance, conceptualization or time representation, 
spatial and/or planning abilities, and detection of perseveration / pull to stimulus. 
3. Verbal fluency: according to a recent study by Vaughan, Coen, Kenny and Lawlor 
(2016), the inclusion of a semantic fluency task that serves as a comparison with 
phonemic fluency may add significant value to the screening for MCI and dementia, 
and can be quickly added to any assessment protocol. This study found that the 
semantic advantage (i.e. better performance for animal versus letter F fluency) 
persists into later life in a population-based sample of community-dwelling older 
adults, and that this pattern is reversed in Alzheimer’s dementia (i.e. loss of semantic 
advantage in Alzheimer’s disease, yielding a phonemic advantage). Hence, the 
inclusion of both types of fluency tasks and the comparison of their performance (in 
the form of discrepancy scores between phonemic and semantic fluency, for example) 
can help distinguishing between normal cognitive aging and defective cognitive 
aging. From our BPA perspective, based on existing literature (Troyer, 2000), it is 
also important to consider the following indices (1) registering answers in 15 second 
intervals (i.e. 0-15, 15-30, 30-45 and 45-60 seconds intervals), (2) set loss errors (i.e. 
errors that violate the instructions given) and (3) indexes for clustering (for measuring 
semantic categorisation) and switching (as a proxy for cognitive flexibility) can be 
generalized to each and every test that uses verbal fluency as a part of the cognitive 
assessment. According to Troyer et al. (1997), an examination of clustering and 
switching scores can provide information about why a particular participant performs 
well or poorly on these tasks, and these are sensitive to the effects of age and to 
conditions of divided attention. 
4. Similarities: As all the MoCA, STMS, and the Brief KSCA-r comprise a similarities 
subtest for abstract thinking, the examples in Table 3 in relation to the error analysis 
included in the MoCA can be extended to the rest of the tests as well, as a way to 
capture subtle abstract thinking differences that may help differentiate between 
different neurocognitive conditions.  
(INSERT TABLE 3 HERE) 
5. Orientation questions: A confusion in the day of the week for one day (i.e. saying it is 
Thursday when it is actually Friday) and a confusion on the season of the year 
(mainly, between Summer and Autumn) may not show subtle differences between 
healthy individuals. It is yet to be seen how the administration of these types of 
questions can give rise to different conclusions with participants with MCI and 
dementia, as a wrong identification of time and space becomes a clearer symptom of 
underlying cognitive deficits. 
6. Short-term recall of words: MOCA, ACE-III, RUDAS, SLUMS and STMS include 
short term recall of 3 to 5 words (depending on the test). Separately, the word recall in 
the Brief KSCA-r rises to 10 words and has a free recall and a recognition task, which 
is closer to the paradigm used in tests like the California Verbal Learning Test 
(CVLT) (Delis et al., 1987) or the Philadelphia (repeatable) Verbal Learning Test 
(P(r)VLT) (Price et al., 2004). Depending on the needs of the clinician, a decision 
needs to be made on the number of words, as the qualitative approach may differ 
depending on the number of items used. For lists from 3 to 5 words, a free recall 
followed by category cues and either phonetic or a recognition task is appropriate. 
However, for an in-depth assessment of memory using the P(r)VLT that includes 
long-term recall (as long as it may be with a 20 minute delay, instead of the 5 minute 
delay used in the cognitive screening measures used here), it may be necessary to 
include or explore other additional indices. So far, the work undertaken included the 
consideration of the following qualitative indices: serial order, primacy and recency 
effect, gained and lost access, intrusions and Perseverative errors, and repetitions. 
7. For Digit Span, it was concluded that there is a need to administer both forward and 
backward digits as they rely on different cognitive processes domains and thus on 
different strategies. What needs to be considered is which series length is the most 
appropriate for both forward and backward digits. The original MoCA only tested a 
series of 4 digits forward and a series of 3 digits backwards. We introduced 2 series of 
5 digits forwards and 2 series of 4 digits backwards to test the limits. However, the 
STMS includes series of 5, 6 and 7 digit forwards that resemble the series used in 
Wechsler Memory Scales. In any case, the qualitative indices that have already been 
developed (as in Lamar et al., 2013) may be used regardless of the length of the series. 
These indices are: (1) percentage of digits recalled in any order [(total number of 
correct digits in any order/total possible correct)*100], (2) percentage of digits 
recalled in serial order [(total number of correct digits in serial order/(total possible 
correct)*100], (3) omissions, (4) additions, (5) substitutions, and (6) capture errors 
(e.g. for 1-4-9-3, “3-4-9-1”; and for 7-2-8-6, “6-7-8-2”). 
 Conclusion: future directions in the screening of MCI and dementia 
Modification of classic cognitive instruments using a process-based approach is not new and 
some of the best existing examples are the Wechsler Intelligence Scales for Adults revised as 
a Neuropsychological Instrument (WAIS-R-NI, Kaplan et al., 1991) and the Delis-Kaplan 
Executive Function System (D-KEFS) (Delis et al., 2001), which mainly integrates a 
compilation of nine classic tests for the assessment of executive functions. For specific 
assessment in older populations, the Kaplan-Baycrest Neurocognitive Assessment was 
developed based on the principles of the process approach (Leach et al., 2000). However, for 
the process-based approach to neuropsychological assessment to gain popularity in the aim to 
improve classic versions of briefer cognitive screening tests, research is now required in order 
to quantify the qualitative observations derived from applying this BPA to test taking 
behaviours observed during cognitive screening test performance and psychometric analysis 
of the validity and clinical utility of test modifications is also required (Erickson, 1995). We 
consider that this effort is justified and we expect that future versions of cognitive screening 
tests modified using a BPA will highlight the benefits of paying attention to qualitative 
features of test performance when trying to identify subtle features suggestive of MCI and/or 
dementia. Additionally, it would be interesting to extend the scope of the identification of 
subtle features to ‘cognitive frailty’, defined as a particular state of cognitive vulnerability in 
MCI and other similar clinical entities exposed to vascular risk, with a subsequent increased 
progression to vascular dementia (VaD) (Ruan et al., 2017). This would, together with the 
consideration of features of Subjective Cognitive Decline (SCD) (understood as a state of 
experienced cognitive difficulties that may take place as early as 5 years before the onset of 
MCI (Jessen et al., 2014; Molinuevo et al., 2017; Ruan et al., 2017)), allow clinicians to 
administer a more accurate process-based screening to rule out different preclinical entities. 
We do, however, recognise that no cognitive screening test on its own can be considered a 
valid replacement for a more in-depth neuropsychological assessment. 
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Table 1. The QUADAS Checklist (Adapted from Whiting et al., 2003) 
Question to consider (Possible answers: Yes, No, Unclear) 
1. Was the spectrum of patients representative of the patients who will receive the test in 
practice? 
2. Were selection criteria clearly described? 
3. Is the reference standard likely to correctly classify the target condition? 
4. Is the time period between reference standard and index test short enough to be 
reasonably sure that the target condition did not change between the two tests? 
5. Did the whole sample or a random selection of the sample, receive verification using 
a reference standard of diagnosis? 
6. Did patients receive the same reference standard regardless of the index test result? 
7. Was the reference standard independent of the index test (i.e. the index test did not 
form part of the reference standard)? 
8. Was the execution of the index test described in sufficient detail to permit replication 
of the test? 
9. Was the execution of the reference standard described in sufficient detail to permit its 
replication? 
10. Were the index test results interpreted without knowledge of the results of the 
reference standard? 
11. Were the reference standard results interpreted without knowledge of the results of the 
index test? 
12. Were the same clinical data available when test results were interpreted as would be 
available when the test is used in practice? 
13. Were uninterpretable/ intermediate test results reported? 
14. Were withdrawals from the study explained? 
 Table 2. Screening tools that may potentially benefit from a process-based approach 
Test Name Acronym Author 
(Year) 
Domains Assessed Administration Time 
(Minutes) 
Montreal Cognitive 
Assessment  
MoCA (full 
version and 
short version) 
Nasreddine 
et al. (2005) 
Short term memory, 
visuospatial abilities, 
cognitive flexibility, 
attention, 
concentration, working 
memory, language, 
verbal fluency, time 
and spatial orientation 
10-15 
Addenbrooke's 
Cognitive 
Examination –Third 
Edition 
ACE-III Hsieh et al. 
(2013) 
Orientation, 
registration, attention 
and concentration, 
memory (recall, 
anterograde memory, 
retrograde memory), 
verbal fluency (p, 
animals), language 
(comprehension, 
writing, repetition, 
naming, reading), 
visuospatial abilities, 
perceptual abilities, 
recall, recognition 
20 
(Brief) Kingston 
Standardized 
Cognitive 
Assessment -Revised 
BKSCA-R Hopkins et 
al. (2005)  
Orientation, word 
recall, abstract 
thinking, spatial 
inversion, clock 
drawing, motor 
perseveration, word 
delayed recall, word 
recognition 
30 
Rowland Universal 
Dementia 
Assessment Scale 
RUDAS Storey et al. 
(2004) 
memory, language, 
visual context, visual-
spatial 
6-10 
Sant Louis 
University Mental 
Status Exam 
SLUMS Tariq et al. 
(2006) 
memory, language, 
visual context, visual-
spatial 
6-10 
Short Test of Mental 
Status 
STMS Kokmen, 
Naessens, & 
Offord 
(1987) 
Attention, immediate 
memory, calculus, 
abstraction, copy and 
construction, 
information, recall. 
5 
Repeatable Battery 
for 
Neuropsychological 
Status 
RBANS Randolph et 
al. (1998) 
Immediate memory, 
visuospational and 
visuoconstructional, 
attention, language, 
delayed memory 
30 
 
 
  
Table 3. Error analysis in similarities subtest (examples for the MoCA) 
Error 
Category 
Error Type Description Example 
 
 
In-Set 
Vague Superordinate, but 
superficial categorical 
response 
Train-Bicycle: “they go fast” 
Watch-Ruler: “you can use 
them” 
Subordinate Response that relates to 
shared concrete attributes 
or to highly specific 
properties about the test 
items that may not be 
correct in all instances 
Train-Bicycle: “both have 
wheels” 
Watch-Ruler: “both have 
numbers” 
 
 
 
Out-of-Set 
One Object Response that pertains to 
only one member of the 
word pair 
Train-Bicycle: “one is the like 
other minus the engine” 
Watch-Ruler: “the watch tells 
the time” 
Juxtaposition Description of how one 
member of the word pair 
might interact with the 
other member 
Train-Bicycle: “the bicycle can 
go inside the train” 
Watch-Ruler: “the ruler can 
measure the watch” 
Different Description of how the 
items of the word pair are 
different 
Train-Bicycle: “one has a motor 
and the other one has not” 
Watch-Ruler: “one is round and 
the other one is rectangular” 
 
Figure 1. PRISMA Flow Diagram for the identification and selection of screening tests 
for early detection Mild Cognitive Impairment potentiallly modifiable using a process-
based approach (PBA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Reasons: the test was excluded for measuring less than 3 relevant cognitive functions (n=51); the test itself or 
further information about the test could not be located (n=13); the test was informant-based (n=9); the test was 
for later stages of a well-established diagnosis (n=7); the test was administered on the phone (n=2); the test was 
not in English (n=2). 
Total number of tests 
found through databases 
(n =  146) 
Additional tests found 
through other sources 
(n = 14) 
Tests identified after duplicates 
removed 
(n = 153) 
Tests excluded 
(already conceived 
or modified using a 
PBA) (n = 48) 
Tests assessed for 
eligibility 
(n = 105) 
Test excluded for 
specific reasons1 
(n =  84) 
 
Tests included in 
qualitative 
synthesis 
(n =  21) 
Total tests finally 
selected for 
modification using 
a PBA 
(n =  7) 
Test excluded after 
quality review 
(n =  14) 
 
